Nasheed M. Hossain

Hematology

3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma.

Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 09, 2026

Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single-Institution Retrospective Analysis.

Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single-Institution Retrospective Analysis.

Journal: Practical radiation oncology

Published: December 16, 2025

Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation.

Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation.

Journal: British journal of haematology

Published: September 02, 2025

Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

Journal: Nature communications

Published: August 03, 2025

Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.

Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.

Journal: British journal of haematology

Published: March 26, 2025

Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.

Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.

Journal: Blood neoplasia

Published: March 10, 2025

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Journal: Blood advances

Published: February 11, 2025

Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.

Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.

Journal: European journal of haematology

Published: September 22, 2024

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.

Journal: Blood cancer journal

Published: April 01, 2024

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities.

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities.

Journal: Blood advances

Published: December 19, 2023

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.

Journal: Leukemia

Published: December 15, 2023

Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.

Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.

Journal: Transplantation and cellular therapy

Published: May 07, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026